A to Z / Immune
Thymagen
Also known as Glu-Trp, thymus bioregulator.
Best known for The synthetic successor to Thymalin
Evidence★☆☆☆☆
Safety dataLargely unknown
Route Injectable · oral · nasal
United StatesNot approved
AustraliaNot listed by name; unapproved therapeutic good
as at 16 September 2026
What it is and what it does
Thymagen is a synthetic dipeptide from the Russian bioregulator programme, developed as a defined-molecule successor to the thymus extract Thymalin. It is studied in Russia for immune support, and is not approved in Western markets.
What the full entry covers
The book carries the rest of this entry:
- Where the research stands, with every claim cited
- What people commonly ask, and what the research shows so far
- Dosing in four labelled bands, described and not recommended
- Side effects, serious risks, cautions and interactions
- Questions to discuss with your doctor
- How it compares with Thymalin, Thymulin, Thymosin Alpha-1, Vilon
Related entries
A certificate of analysis tells you what is in a vial. The evidence rating above tells you whether the compound has been shown to work in humans. Neither answers the other's question. How to read a certificate of analysis.
This page describes what is known and not known about Thymagen. It is not medical advice and not a recommendation to use it.